A detailed history of Abrdn PLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Abrdn PLC holds 6,537 shares of EXAS stock, worth $455,236. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,537
Previous 88,478 92.61%
Holding current value
$455,236
Previous $3.74 Million 88.1%
% of portfolio
0.0%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$42.43 - $70.83 $3.48 Million - $5.8 Million
-81,941 Reduced 92.61%
6,537 $445,000
Q2 2024

Aug 09, 2024

SELL
$41.33 - $74.26 $903,267 - $1.62 Million
-21,855 Reduced 19.81%
88,478 $3.74 Million
Q1 2024

May 08, 2024

BUY
$56.27 - $73.77 $237,853 - $311,825
4,227 Added 3.98%
110,333 $7.62 Million
Q4 2023

Jan 31, 2024

BUY
$59.06 - $75.72 $2.04 Million - $2.61 Million
34,494 Added 48.17%
106,106 $7.85 Million
Q3 2023

Nov 06, 2023

BUY
$65.94 - $99.04 $197,292 - $296,327
2,992 Added 4.36%
71,612 $4.89 Million
Q2 2023

Jun 20, 2024

BUY
$62.68 - $95.05 $291,023 - $441,317
4,643 Added 7.26%
68,620 $6.44 Million
Q2 2023

Aug 04, 2023

BUY
$62.68 - $95.05 $291,023 - $441,317
4,643 Added 7.26%
68,620 $6.44 Million
Q1 2023

Jun 20, 2024

BUY
$47.19 - $70.77 $727,245 - $1.09 Million
15,411 Added 31.73%
63,977 $4.34 Million
Q1 2023

Apr 28, 2023

BUY
$47.19 - $70.77 $727,245 - $1.09 Million
15,411 Added 31.73%
63,977 $4.34 Million
Q4 2022

Jun 20, 2024

SELL
$30.35 - $53.15 $1.87 Million - $3.28 Million
-61,767 Reduced 55.98%
48,566 $2.4 Million
Q4 2022

Feb 09, 2023

BUY
$30.35 - $53.15 $182,858 - $320,228
6,025 Added 14.16%
48,566 $2.4 Million
Q3 2022

Nov 10, 2022

BUY
$31.97 - $49.37 $637,833 - $984,980
19,951 Added 88.32%
42,541 $1.38 Million
Q2 2022

Aug 05, 2022

BUY
$35.61 - $76.23 $71,398 - $152,841
2,005 Added 9.74%
22,590 $890,000
Q1 2022

May 04, 2022

BUY
$57.56 - $82.54 $152,591 - $218,813
2,651 Added 14.78%
20,585 $1.48 Million
Q4 2021

Feb 08, 2022

BUY
$72.5 - $100.68 $25,810 - $35,842
356 Added 2.03%
17,934 $1.4 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $378,015 - $519,645
4,189 Added 31.29%
17,578 $1.68 Million
Q2 2021

Aug 10, 2021

SELL
$93.66 - $139.27 $230,871 - $343,300
-2,465 Reduced 15.55%
13,389 $1.66 Million
Q1 2021

May 06, 2021

BUY
$116.57 - $155.01 $20,749 - $27,591
178 Added 1.14%
15,854 $2.09 Million
Q4 2020

Feb 10, 2021

BUY
$99.61 - $142.12 $54,088 - $77,171
543 Added 3.59%
15,676 $2.08 Million
Q3 2020

Oct 21, 2020

SELL
$72.92 - $102.01 $301,305 - $421,505
-4,132 Reduced 21.45%
15,133 $1.54 Million
Q2 2020

Aug 10, 2020

BUY
$55.75 - $92.75 $44,823 - $74,571
804 Added 4.36%
19,265 $1.68 Million
Q1 2020

May 13, 2020

BUY
$37.9 - $104.44 $13,378 - $36,867
353 Added 1.95%
18,461 $1.07 Million
Q4 2019

Feb 18, 2020

BUY
$77.66 - $99.74 $84,338 - $108,317
1,086 Added 6.38%
18,108 $1.67 Million
Q3 2019

Nov 13, 2019

BUY
$90.37 - $122.49 $885,626 - $1.2 Million
9,800 Added 135.7%
17,022 $1.54 Million
Q2 2019

Aug 13, 2019

BUY
$89.51 - $118.04 $646,441 - $852,484
7,222 New
7,222 $852,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.